QL
JBIO icon

Quarry LP’s Jade Biosciences JBIO Stock Holding History

Quarry LP’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$867 Buy
+39
New +$813 ﹤0.01% 2021

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Quarry LP's JBIO Position: Q2 2026 in Review

Quarry LP opened a new position in Jade Biosciences (JBIO) in Q2 2026: 39 shares worth $867. The stake represents ﹤0.01% of the portfolio and ranks #2021 among its holdings.

153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Quarry LP held 39 shares of Jade Biosciences worth $867 as of Q2 2026.
  • Jade Biosciences was a new Quarry LP position in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2021 holding.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.